Immunophenotyping of peripheral blood CLL cells is a widely available cornerstone of CLL diagnosis [6, 7], and some markers obtained by flow cytometric analysis like CD38 and CD49d are well established to predict outcome [8–11]. The gene discussed is ITGA4; the disease is B-cell chronic lymphocytic leukemia.